Lubrizol Launches Soft TPU for Interventional Devices

Lubrizol has launched Tecothane Soft AR-65A TPU, a medical-grade material for interventional medical devices. Medical Design & Outsourcing reported the launch in a news release covering the material’s intended device application and performance characteristics.

Material positioned for interventional devices

According to Medical Design & Outsourcing, Tecothane Soft AR-65A TPU is designed for use in interventional medical devices. The material combines 65A performance with softness, chemical resistance and thin-wall processability.

The publication described the product as a very soft, 100% TPU. For medical-device sales professionals working with interventional-device manufacturers, the announcement centers on a material option that brings together softness and processing characteristics for device development discussions.

Key characteristics highlighted in the announcement

• Medical-grade material for interventional medical devices
• 65A softness
• Chemical resistance
• Thin-wall processability
• 100% TPU composition

Medical Design & Outsourcing identified Tecothane Soft AR-65A TPU as Lubrizol’s newly launched material in the interventional-device segment. The reported attributes provide a focused set of talking points for professionals evaluating material specifications in medical-device programs.

Sales teams can use the launch to frame conversations around the material requirements cited by the publisher: softness, chemical resistance and thin-wall processability. The announcement also underscores the role of specialty polymers in interventional-device material selection.

Commercial relevance for device-facing teams

For professionals serving medical-device accounts, the launch creates a timely reason to revisit how interventional-device customers assess medical-grade TPU materials. Medical Design & Outsourcing’s report specifically associates the new Tecothane Soft AR-65A TPU with interventional applications and highlights its 65A performance.

Lubrizol’s announcement is a product-development update for teams whose customers are considering material choices for interventional devices. The reported combination of medical-grade positioning, softness, chemical resistance and thin-wall processability defines the core focus of the launch.